Quality control in molecular immunohistochemistry

Por True, Lawrence D.
Publicado em 2008

Methodological requirements for valid tissue-based biomarker studies that can be used in clinical practice

Por True, Lawrence D
Publicado em 2014

Atlas of diagnostic immunohistopathology /

Por True, Lawrence D.
Publicado em 1990.

Quantum Dots for Molecular Pathology : Their Time Has Arrived

Por True, Lawrence D., Gao, Xiaohu
Publicado em 2007

Characterization of Prostate Cell Types by CD Cell Surface Molecules

Por Liu, Alvin Y., True, Lawrence D.
Publicado em 2002

Multicolor multicycle molecular profiling (M3P) with quantum dots for single-cell analysis

Por Zrazhevskiy, Pavel, True, Lawrence D., Gao, Xiaohu
Publicado em 2013

The Impact of Pre-analytic Factors In The Design and Application of Integral Biomarkers for Directing Patient Therapy

Por Hewitt, Stephen M., Badve, Sunil S., True, Lawrence D.
Publicado em 2012

Heterogeneity in Primary and Metastatic Prostate Cancer as Defined by Cell Surface CD Profile

Por Liu, Alvin Y., Roudier, Martine P., True, Lawrence D.
Publicado em 2004

Protease-Activated Receptor-1 is Upregulated in Reactive Stroma of Primary Prostate Cancer and Bone Metastasis

Por Zhang, Xiaotun, Wang, Wenbin, True, Lawrence D., Vessella, Robert L., Takayama, Thomas K.
Publicado em 2009

Tumor suppressor BRCA1 is expressed in prostate cancer and controls IGF-I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner

Por Schayek, Hagit, Haugk, Kathy, Sun, Shihua, True, Lawrence D., Plymate, Stephen R., Werner, Haim
Publicado em 2009

Human cancers express a mutator phenotype

Por Bielas, Jason H., Loeb, Keith R., Rubin, Brian P., True, Lawrence D., Loeb, Lawrence A.
Publicado em 2006

Locus-specific gene repositioning in prostate cancer

Por Leshner, Marc, Devine, Michelle, Roloff, Gregory W., True, Lawrence D., Misteli, Tom, Meaburn, Karen J.
Publicado no Mol Biol Cell (2016)

Transcriptomes of human prostate cells

Por Oudes, Asa J, Campbell, Dave S, Sorensen, Carrie M, Walashek, Laura S, True, Lawrence D, Liu, Alvin Y
Publicado em 2006

The urologic epithelial stem cell database (UESC) – a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder

Por Pascal, Laura E, Deutsch, Eric W, Campbell, David S, Korb, Martin, True, Lawrence D, Liu, Alvin Y
Publicado em 2007

Histopathologic Assessment of Prostate Cancer Bone “Osteoblastic” Metastases

Por Roudier, Martine P, Morrissey, Colm, True, Lawrence D, Higano, Celestia S, Vessella, Robert L, Ott, Susan M
Publicado em 2008

Histological changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in high-risk prostate cancer patients

Por O’Brien, Catherine, True, Lawrence D., Higano, Celestia S., Rademacher, Brooks L. S., Garzotto, Mark, Beer, Tomasz M.
Publicado em 2010

Differences in Upgrading of Prostate Cancer in Prostatectomies between Community and Academic Practices

Por Lee, Franklin, Gottsch, Henry, Ellis, William J., True, Lawrence D., Lin, Daniel W., Wright, Jonathan L.
Publicado em 2013

A Quantitative Model for the Dynamics of Serum Prostate-Specific Antigen as a Marker for Cancerous Growth : An Explanation for a Medical Anomaly

Por Swanson, Kristin R., True, Lawrence D., Lin, Daniel W., Buhler, Kent R., Vessella, Robert, Murray, James D.
Publicado em 2001

Oxidative DNA Damage in the Prostate May Predispose Men to a Higher Risk of Prostate Cancer

Por Wu, Jennifer D, Lin, Daniel W, Page, Stephanie T, Lundgren, Ashley D, True, Lawrence D, Plymate, Stephen R
Publicado em 2009

Variability in the androgen response of prostate epithelium to 5-alpha reductase inhibition: implications for prostate cancer chemoprevention

Por Mostaghel, Elahe A., Geng, Linda, Holcomb, Ilona, Coleman, Ilsa M., Lucas, Jared, True, Lawrence D., Nelson, Peter S.
Publicado em 2010